cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihaemorrhagiás - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
echovist 200 por és oldószer szuszpenziós injekcióhoz
bayer schering pharma ag - galaktóz -
engemycine 100 mg/ml oldatos injekció szarvasmarhák, juhok és sertések részére a.u.v.
intervet international b.v. - oxitetraciklin-hidroklorid - oldatos injekció - oxytetracycline - szarvasmarha, juh, sertés
allerderm foam cleanser
virbac - enrofloxacin - külsoleges oldat - enrofloxacin - kutya, macska
solv-ac t 100 tabletta
vomelin kft. - acetilcisztein -
solv-ac t 200 tabletta
vomelin kft. - acetilcisztein -